NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq:IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in September:
Read more at prnewswire.comImmunic to Participate in Industry and Investor Conferences in September
PR Newswire - Wed Sep 6, 2023 Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here